ACTRN12617001346369RecruitingPhase 1
The pharmacokinetics and pharmacodynamics of a single dose of febuxostat (80 mg) in healthy subjects.
St Vincent's Hospital, Sydney0 sites10 target enrollmentStarted: September 25, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Non-randomised trial
- Primary Purpose
- Treatment
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 18 Years to 70 Years (—)
- Sex
- All
Inclusion Criteria
- •Healthy subjects
Exclusion Criteria
- •Subject with a history of any chronic disease.
Investigators
Similar Trials
Completed
Not Applicable
The effect of body weight on rivaroxaban disposition in healthy human volunteersRivaroxaban disposition in healthy human volunteers (obese vs non-obese population)ISRCTN12520248Qatar University36
Recruiting
Phase 1
Evaluation of intravenous or subcutaneous administration of ublituximab in patients with multiple sclerosisCTIS2023-509555-13-00Tg Therapeutics Inc.60
Active, not recruiting
Not Applicable
Pharmacokinetics, pharmacodynamics and safety of a new Leuprolide acetate 22.5 mg depot formulation, when given as palliative treatment to prostate cancer patientsMedDRA version: 8.1Level: LLTClassification code 10007113Term: Cancer of prostateProstate cancerEUCTR2006-005964-24-GBItalfarmaco S.p.A.20
Active, not recruiting
Not Applicable
Action of amlodipine oral solution in childreHypertensionEUCTR2013-005323-17-NLErasmus MC
Completed
Not Applicable
Pharmacokinetic and pharmacodynamic properties of amlodipine oral liquid in the pediatric populatiohigh blood pressure10057166HypertensionNL-OMON41645Erasmus MC, Universitair Medisch Centrum Rotterdam20